← FDA Drug Approvals (Drugs@FDA)
LENALIDOMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT · Approved 2023-08-03
Drug application
- FDA Application #
ANDA213405- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LENALIDOMIDE
- Generic name
- Lenalidomide
- Active ingredients
- LENALIDOMIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TORRENT
- First approval
- 2023-08-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown